Frequently Asked Questions
1. What is Phase I clinical trial?
There are three major stages of clinical trials for drug development: Phase I, II and III. Phase I trials are conducted in a small group of people to test a new drug or treatment for its tolerability and safety, determine a safe dosage range, and identify side effects.
2. How to get the information on current studies?
You can click Current Studies to access a list of studies currently being conducted in Lilly-NUS.
3. How do I know if I am eligible to participate?
You are required to undergo a medical/health screening. It may include:
- Clinical Examination
All these tests are performed at our expense. Results will be reviewed by the physician at Lilly-NUS. If you qualify for screening, you will have the opportunity to discuss the findings of the tests with our medical staff. Additionally, suitable participants may be offered the opportunity to join future research studies.
4. What are the potential risks and benefits of being a volunteer?
All the clinical trials conducted by Lilly-NUS are reviewed and approved by Singapore Health Sciences Authority (HSA) and The National Health Group Domain Specific Review Board (DSRB). The details of the trial including potential risks and benefits will be explained to you before you give consent to participate.Your participation is entirely voluntary.
5. Would my health information be released to the public?
Information collected for the trial will be kept confidential, only authorized personnel, regulatory agencies (HSA, DSRB) will be granted direct access to your records.
6. How would I be compensated?
Volunteers would be compensated for time and inconvenience for study and screening activities.
7. How to register my interest?
Click here to register online.